Varian announced today that it received FDA investigational device exemption IDE to advance its Flash clinical research program. Flash therapy, an experimental treatment modality, was designed to deliver radiation therapy at ultra-high dose rates in typically less than one second. The Siemens Healthineers company will conduct the feasibility study of Flash therapy for the treatment […]
Oncology
Inovio names new chief medical officer
Inovio (Nasdaq:INO) announced today that it appointed Dr. Michael Sumner as its new chief medical officer (CMO). Sumner will oversee Inovio’s clinical-stage pipeline of DNA medicines, global clinical development, clinical operations and biostatistics efforts, along with regulatory affairs, pharmacovigilance and medical affairs. He will also serve on the company’s executive leadership team and report to President […]
Illumina, Merck launch test for cancer development, progression insights
Illumina (Nasdaq:ILMN) announced today that it launched a new research test, co-developed with Merck (NYSE:MRK). The jointly developed test adds the assessment of a new genomic signature to the already distributed TruSight Oncology 500 assay, enabling researchers to unlock deeper insights about the tumor genome by identifying genetic mutations used in the evaluation of homologous […]
FDA grants breakthrough nod for Carthera’s SonoCloud-9
Carthera announced today that it received FDA breakthrough device designation for its SonoCloud-9 system. Paris-based Carthera designed SonoCloud-9 for implantation in a skull window below the skin. Once in place, the device becomes invisible. When activated for a few minutes using a transdermal needle connected to an external control unit, it uses low-intensity pulsed ultrasound […]
Sidekick Health and Eli Lilly partner on digital therapeutics for breast cancer
Sidekick Health today announced a collaboration on an integrated digital therapeutics solution in conjunction with Eli Lilly (NYSE:LLY). The collaboration between the companies will mark the first phase of a relationship between Sidekick and Lilly, which starts with a digital therapeutic offering for patients battling breast cancer. According to a news release, the first phase […]
Onkos Surgical raises $26.5M
Surgical oncology device maker Onkos Surgical today filed an amendment to an SEC Form D confirming the sale of $26.5 million in equity. The equity offering had its first sale on Aug. 31, 2021 and today reached $26,500,001. That leaves no amount remaining to be sold. According to the amended SEC Form D, 16 investors […]
DermaSensor raises $10M as it braces for U.S. launch
DermaSensor announced today that it raised an additional $10 million as it prepares for a commercial launch in the U.S. Miami, Florida-based DermaSensor’s $10 million fundraising accompanies news that the company met all primary endpoints for two FDA pivotal studies, setting it up to potentially offer the only FDA-cleared, automated skin cancer detection tool on […]
Ibex wins CE mark for AI-powered gastric cancer detection tech
Ibex Medical Analytics announced today that it received CE mark approval for its Galen gastric cancer detection solution. Tel Aviv, Israel-based Ibex uses artificial intelligence (AI) and machine learning technology to power its Galen platform for cancer diagnostics based on hundreds of thousands of image samples scanned from biopsy slides through digital pathology. Galen won […]
Onkos Surgical to acquire Stryker’s Juvenile Tumour System
Onkos Surgical announced today that it agreed to acquire the Juvenile Tumour System (JTS) from Stryker (NYSE:SYK). Parsippany, New Jersey–based Onkos entered into a definitive agreement with the orthopedic technology giant over the system designed to enable limb stabilization and growth in pediatric patients affected by bone cancers, severe arthropathy, severe trauma, revisions, oncology and […]
How fluorescent signals could allow for deeper sensor implants in the brain
Engineers at the Massachusetts Institute of Technology have developed a photonic technique for fluorescent sensors that could improve sensor signals deep in the body. Fluorescent sensors are typically used to label and image a variety of molecules to give a unique glimpse inside living cells. However, the method has been limited to cells grown in […]
Accuray partners with Limbus AI on adaptive radiotherapy
Accuray (Nasdaq:ARAY) and Limbus AI announced today that they are partnering to augment Accuray’s adaptive radiotherapy capabilities. The partnership aims to leverage Limbus’ artificial intelligence (AI)-driven auto contouring algorithms to enable a streamlined treatment planning process. Sunnyvale, California-based Accuray and Saskatchewan, Canada-based Limbus AI anticipate an integrated offering will be made available beginning in 2023, […]
